首页|乳管镜下地塞米松、庆大霉素、a-糜蛋白酶治疗溢液期浆细胞性乳腺炎的疗效观察

乳管镜下地塞米松、庆大霉素、a-糜蛋白酶治疗溢液期浆细胞性乳腺炎的疗效观察

FDS, gentamicin, dexamethasone a- chymotrypsin treatment discharge stage of plasma cel mastitis

扫码查看
目的:探讨乳管镜下地塞米松、庆大霉素、a-糜蛋白酶治疗溢液期浆细胞性乳腺炎的疗效。方法对我院2009年7月-2013年6月间溢液期浆细胞性乳腺炎患者29例,给予乳管镜下病变处乳管地塞米松、庆大霉素、a-糜蛋白酶混合液冲洗治疗,并进行疗效分析。结果29例患者,治疗1次治愈3例(10.3%),治疗2次治愈5例(17.2%),治疗3次以上治愈19例(65.5%),2例转行其他治疗。结论乳管镜为溢液期浆细胞性乳腺炎患者提供了一种新的、有效的治疗方法。
To explore the curative effect of FDS, gentamicin, dexamethasone a- chymotrypsin treatment discharge stage of plasma cellmastitis.Methods in our hospital from 2009 July to 2013 June 29 cases of liquid phase discharge plasma cellmastitis patients, given FDS lesions breast duct, gentamicin, dexamethasone a- chymotrypsin mixture irrigation treatment, and to analyze the effects of. Results of the 29 patients treated, 1 cured 3 cases (10.3%), 2 times of treatment 5 cases were cured (17.2%), treatment of more than 3 cured 19 cases (65.5%), 2 cases turned to other treatment. Conclusion fiberoptic ductoscopy provides a new, effective treatment for discharge period with plasma cellmastitis.

ductoscopydischarge stage of plasma cellmastitis

张腾华

展开 >

河南省濮阳市妇幼保健院乳腺科 457000

乳管镜 溢液期浆细胞性乳腺炎

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(7)
  • 4
  • 1